[Skip to Content]
[Skip to Content Landing]
Views 782
Citations 0
Comment & Response
September 2017

Ketamine for the Treatment of Depression

Author Affiliations
  • 1Neuroimaging Labs, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
  • 2Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
JAMA Psychiatry. 2017;74(9):970. doi:10.1001/jamapsychiatry.2017.1770

To the Editor We congratulate Sanacora et al1 for the publication of their consensus statement in JAMA Psychiatry. The growing amount of literature on this topic has generated interest among patients and physicians, which called for such an important document as the basis for decision-making societies, health care professionals, and regulatory authorities. Until official approval of depression as an indication, off-label uses by medical experts assuming legal, scientific, and medical hazards will increase. On the other hand, ketamine clinics or ketamine wellness centers already offer ketamine as outpatient treatment with unscientific and dangerous methods. To overcome the lack of regulation, consensus statements and their dissemination are of utmost importance.

First Page Preview View Large
First page PDF preview
First page PDF preview
×